| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 117 | 97.9 | +19.5% |
| EBITDA | 18.3 | 11.2 | +63.2% |
| EBITDA margin | 15.7% | 11.5% | +4.2 pts |
| Profit before tax | 16.9 | 10.1 | +67.3% |
| Net profit | 12.3 | 7.3 | +68.6% |
| EPS | ₹1.34 | ₹0.80 | +67.5% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 |
|---|
| 99.8 | — | — | — | — | |
| 1.3 | 1.3 | 0.2 | 3.0 | 5.0 | |
| 61.8 | 61.8 | 41.9 | 63.9 | 41.0 | |
| 160 | — | — | — | — | |
| 267 | 248 | 246 | 269 | 272 | |
| — | +0.9% | −8.6% | −1.2% | — | |
| 21.6 | 14.5 | 9.6 | 1.0 | 11.9 | |
| 8.1% | 5.9% | 3.9% | 0.4% | 4.4% | |
| 20.9 | 13.8 | 9.1 | 0.5 | 11.5 | |
| 12.2 | 7.2 | 3.5 | −4.2 | 5.7 | |
| 4.6% | 2.9% | 1.4% | −1.6% | 2.1% | |
| ₹1.34 | ₹0.79 | ₹0.39 | −₹0.45 | ₹0.62 | |
| — | +104.7% | +184.8% | −172.9% | — | |
| — | −13.7 | 24.1 | −15.3 | 11.9 | |
| — | −0.8 | −0.2 | −2.8 | −1.6 | |
| −14.5 | −14.5 | 23.9 | −18.2 | 10.3 | |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 99.8 | |
| - Cash, Equiv & ST Investments | 5.0 | 3.0 | 0.2 | 1.3 | 1.3 | |
| + Total Debt | 41.0 | 63.9 | 41.9 | 61.8 | 61.8 | |
| Enterprise Value | — | — | — | — | 160.4 | |
| Revenue | 272.3 | 269.0 | 245.9 | 248.2 | 267.4 | |
| Growth %, YoY | — | -1.2 | -8.6 | +0.9 | — | |
| EBITDA | 11.9 | 1.0 | 9.6 | 14.5 | 21.6 | |
| Margin % | 4.37 | 0.37 | 3.89 | 5.85 | 8.09 | |
| EBIT | 11.5 | 0.5 | 9.1 | 13.8 | 20.9 | |
| Net Income | 5.7 | -4.2 | 3.5 | 7.2 | 12.2 | |
| Margin % | 2.10 | -1.55 | 1.44 | 2.91 | 4.57 | |
| EPS, Adj (current shares) | 0.62 | -0.45 | 0.39 | 0.79 | 1.34 | |
| Growth %, YoY | — | -172.9 | +184.8 | +104.7 | — | |
| Cash from Operations | 11.9 | -15.3 | 24.1 | -13.7 | — | |
| Capital Expenditures | -1.6 | -2.8 | -0.2 | -0.8 | — | |
| Free Cash Flow | 10.3 | -18.2 | 23.9 | -14.5 | -14.5 | |
Prices at the previous close · figures from the company's filings with NSE
ShreeOswal Seeds And Chemicals (NSE: OSWALSEEDS) had a market capitalisation of ₹99.8 crore at the previous close (₹10.91 a share), a PE ratio of 8.2 on the last four quarters' profit and a price-to-book ratio of 1.96. In FY26 its consolidated net profit was ₹7.2 crore on revenue of ₹248 crore; in Q1 FY27 (April–June 2026) it was ₹12.3 crore, up 68.6% year on year. Its debt-to-equity ratio was 1.21 on 31 March 2026. Promoters held 66.63% of the shares on 30 September 2026.
ShreeOswal Seeds And Chemicals' PE ratio is 8.2 at the previous close (₹10.91 a share): a market capitalisation of ₹99.8 crore divided by consolidated net profit of ₹12.2 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹7.2 crore) it is 13.8.
ShreeOswal Seeds And Chemicals' price-to-book (PB) ratio is 1.96 at the previous close: a market capitalisation of ₹99.8 crore divided by shareholders' equity (book value) of ₹51 crore on 31 March 2026. That is a book value of ₹5.58 per share against a share price of ₹10.91.
ShreeOswal Seeds And Chemicals' book value per share was ₹5.58 on 31 March 2026: shareholders' equity of ₹51 crore divided by the 9.15 crore shares in issue, up 16.7% from ₹4.78 a year earlier. The share price at the previous close was ₹10.91.
ShreeOswal Seeds And Chemicals' market capitalisation was ₹99.8 crore at the previous close: 9.15 crore shares at ₹10.91 each.
No. ShreeOswal Seeds And Chemicals had borrowings of ₹61.8 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 1.21. Its cash and current investments were ₹1.3 crore, so its net debt was ₹60.6 crore.
On 30 September 2026, ShreeOswal Seeds And Chemicals' shares were held by promoters 66.63% and retail and other non-institutional investors 33.37%.
ShreeOswal Seeds And Chemicals' debt-to-equity ratio was 1.21 on 31 March 2026: borrowings of ₹61.8 crore against total equity of ₹51 crore. A year earlier, on 31 March 2025, it was 0.96.
ShreeOswal Seeds And Chemicals' basic earnings per share (EPS) were ₹0.79 in FY26, against ₹0.39 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹1.33.
Promoters held 66.63% of ShreeOswal Seeds And Chemicals on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
ShreeOswal Seeds And Chemicals' net worth — shareholders' equity in its consolidated balance sheet — was ₹51 crore on 31 March 2026, up 16.7% from ₹43.7 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹99.8 crore at the previous close.
In FY26, ShreeOswal Seeds And Chemicals' return on equity (ROE) was 15.2% and its return on capital employed (ROCE) was 27.8%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 8.4% and ROCE 20.9%.
In FY26, ShreeOswal Seeds And Chemicals earned net profit of ₹7.2 crore on revenue of ₹248 crore, against ₹4.2 crore on ₹109 crore for Vaishali Pharma. ShreeOswal Seeds And Chemicals' operating margin was 5.6% (Vaishali Pharma 3.2%) and its return on equity 15.2% (Vaishali Pharma 6.2%).
In FY26, ShreeOswal Seeds And Chemicals generated ₹13.7 crore of cash from operations and spent ₹77 lakh on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹14.5 crore. In FY25 it was ₹23.9 crore.
ShreeOswal Seeds And Chemicals' latest results are for Q1 FY27 (April–June 2026), filed on 13 August 2026: consolidated net profit ₹12.3 crore, up 68.6% from ₹7.3 crore in Q1 FY26; revenue from operations ₹117 crore, up 19.5% year on year.
In FY26 (April 2025–March 2026), ShreeOswal Seeds And Chemicals' consolidated net profit was ₹7.2 crore, up 104.7% from ₹3.5 crore in FY25, on revenue from operations of ₹248 crore (up 0.9%). Over three years, from FY23, net profit was up 26.6%.
ShreeOswal Seeds And Chemicals has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.
On FY26 consolidated figures, against Vaishali Pharma, Tembo Global Industries and Total Transport Systems: ShreeOswal Seeds And Chemicals' operating margin of 5.6% is the second highest of the four (Vaishali Pharma 3.2%, Tembo Global Industries 12.5%, Total Transport Systems 1.8%; peer average 5.8%); its return on equity of 15.2% is the second highest of the four (Vaishali Pharma 6.2%, Tembo Global Industries 27.5%, Total Transport Systems 9.0%; peer average 14.2%).
From ShreeOswal Seeds And Chemicals' own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.